home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

51.53 +0.02 (+0.04%)

Official Closing Price Updated: 4:10 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

45 46 Next >

GSK's Rare Blood Cancer Candidate Goes Under FDA Review ↗

August 17, 2022

Via Benzinga

One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK ↗

August 17, 2022

Via Benzinga

Why IDEAYA Biosciences Shares Plunging Today ↗

August 15, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 15, 2022

On Monday, 31 companies hit new 52-week lows.

Via Benzinga

ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

August 15, 2022

From The Schall Law Firm

Via Business Wire

GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report ↗

August 10, 2022

Via Benzinga

Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment ↗

August 10, 2022

Via Benzinga

Landmark Drug Pricing Reform Bill Passes Congress House ↗

August 15, 2022

The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year...

Via Benzinga

Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus ↗

August 12, 2022

New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

August 12, 2022

From The Schall Law Firm

Via Business Wire

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke ↗

August 11, 2022

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

Via Benzinga

Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy ↗

August 09, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 11, 2022

On Thursday, 22 companies reached new 52-week lows.

Via Benzinga

GSK, PFE, SNY Stocks Fall on Zantac Litigation ↗

August 11, 2022

You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.

Via InvestorPlace

Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms ↗

August 11, 2022

These companies are at the center of lawsuits claiming Zantac causes cancer.

Via Investor's Business Daily

Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

August 11, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 10, 2022

During Wednesday, 52 stocks hit new 52-week lows.

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Dividend Income Update July 2022 ↗

August 09, 2022

The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. Let’s take a look back at...

Via Talk Markets

ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide

August 08, 2022

From GSK plc

Via Business Wire

Biotech Investors: August's Key PDUFA Catalysts You Must Know ↗

July 31, 2022

Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the...

Via Benzinga

Recap Of Friday's Biotech Catalysts - End of The Day Summary ↗

July 29, 2022

Via Benzinga

Stock Market Rally Powers Higher On Fed Rate Hints; Apple, Microsoft, Meta, Amazon, Google Key Earnings: Weekly Review ↗

July 29, 2022

The major indexes made big moves amid key earnings and another big Fed rate hike.

Via Investor's Business Daily

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate ↗

July 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 27, 2022

Via Benzinga

GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus Nephritis

July 27, 2022

From GSK plc

Via Business Wire

IDEAYA's Cancer Candidate Shows Early Tumor Modulation ↗

July 27, 2022

Via Benzinga

The 3 Best Market Sectors for the Second Half of 2022 ↗

July 27, 2022

Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.

Via InvestorPlace

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com